Targeting the undruggable: an interview with Leila Akkari on fighting cancer by rewiring cells
Leila Akkari began her independent career in 2017 as an Assistant Professor at the Netherlands Cancer Institute in Amsterdam after working at Memorial Sloan Kettering Cancer Center in NYC. Two years ago, she was selected as one of the junior members of the Oncode Institute, a virtual group of cancer...
Enregistré dans:
Format: | article |
---|---|
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/629c0b3d4b2c4a6a91d38d13225d42c8 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
KRAS mutation: from undruggable to druggable in cancer
par: Lamei Huang, et autres
Publié: (2021) -
Protein complex evolution does not involve extensive network rewiring.
par: Teunis J P van Dam, et autres
Publié: (2008) -
Stem cells and art: an interview with Yi Arial Zeng on the promising future of the stem cell field
Publié: (2021) -
Developing organoids: an interview with Alice Soragni on 3D biology at the interface of treating cancers and protein aggregation
Publié: (2021) -
Seeing the full picture of brain development: an interview with Aparna Bhaduri on single-cell genomics and developmental neuroscience
Publié: (2021)